Northwestern Medicine investigators are leading a Specialized Program of Research Excellence (SPORE) in brain cancer with a special emphasis on glioblastoma.
A new study has identified genes that, when inhibited, may slow or stop the progression of primary effusion lymphoma.
Faculty, family and friends gathered at a symposium to honor Robert Goldman, PhD, chair of Cell and Molecular Biology, and his distinguished scientific career.
A novel chemotherapy regimen led to improved outcomes for older patients with Hodgkin lymphoma, similar to those of younger patients, according to a Northwestern Medicine clinical trial.
Led by Melissa Simon, MD, MPH, the Center for Health Equity Transformation will build research infrastructure, conduct workforce development and support community partners in the effort to advance population health equity.
A protein facilitating DNA replication during cell cycle also binds microtubules, findings that could inform more effective cancer treatments, according to a recent study published in the Journal of Cell Biology.
The three-dimensional atomic structure of the epigenetic driver COMPASS was solved for the first time in a study published in the journal Cell.
A drug called mogamulizumab significantly improved progression-free survival for patients with cutaneous T-cell lymphoma, according to a study published in The Lancet Oncology.
A bill based in part on research and advocacy at Northwestern amends the Illinois insurance code to require oncofertility coverage, which requires insurance to cover fertility preservation.
The Robert H. Lurie Comprehensive Cancer Center has been awarded a new, five-year $11.5 million grant from the National Cancer Institute to advance translational brain cancer research.